Prostate Cancer - Results from #1100

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification. June 14, 2024

Improving Distress Screening for People with Prostate Cancer: Evaluation of an E-Learning Course to Increase Healthcare Professionals' Knowledge. June 14, 2024

Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy. June 14, 2024

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression. June 14, 2024

'It Just Makes Sense to Me': A qualitative study exploring patient decision-making and experiences with prostate MRI during active surveillance for prostate cancer. June 14, 2024

Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities. June 14, 2024

Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. June 14, 2024

Racial and socioeconomic disparities in surgical care for post-prostate cancer treatment complications: A nationwide Medicare-based analysis. June 14, 2024

Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers. June 14, 2024

The need for precision medicine in managing cardiovascular risk for men receiving ADT. June 14, 2024

Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide. June 13, 2024

Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study. June 13, 2024

Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer. June 13, 2024

Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience. June 13, 2024

Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer. June 13, 2024

Androgen Deprivation Therapy and Outcomes After Radiation Therapy in Black Patients With Prostate Cancer. June 12, 2024

Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era. June 12, 2024

Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease. June 12, 2024

Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer. June 12, 2024

New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy. June 12, 2024

Page 56 of 1454